UCT researchers uncover molecular “switch” that fuels cancer progression
Peer-Reviewed Publication
This September, we're exploring the science behind vaccines. From how they train our immune systems to fight disease to the research shaping their future, vaccines offer an opportunity to discover the science helping protect individuals and communities around the world.
Updates every hour. Last Updated: 22-Oct-2026 07:17 ET (22-Oct-2026 11:17 GMT/UTC)
The research, led by Professor Kevin J. Naidoo working with Dr Lateef Nashed (SCRU Glycobiomedical laboratory) and SCRU computational scientists Dr Tharindu Senapthi and doctoral student Kyllen Dilsook, focused on Mucin 1 (MUC1), a protein that behaves very differently in healthy and cancerous cells due to changes in glycosylation, the process by which sugar molecules attach to proteins. Using a novel “one-pot” synthetic biology method, combined with advanced computer-based reaction simulations, the team recreated the complex conditions found inside the cell’s Endoplasmic Reticulum (ER) and Golgi apparatus.